Review of the use of NOACs Gemma McNally and Paulash Haider had discussed – this. A range of novel oral anticoagulants are in use across the health economy. A strategy for the use of NOACs reflecting latest published evidence is required for discussion at a future APC. Action: PH Chapter 11 was agreed to request Mr Kotta to provide any final comments on –It Chapter 11. Action: AT Lurasidone checking NAVIGO support the inclusion of lurasidone for prescribing in – specialist care only. Action:AT NL CCG Prescribing formulary changes agreed at Engine Room - Net-formulary presentation of the formulary will be able to reflect preferred products proposed by CCGs. Co-Amoxiclav Prescribing in Primary and Secondary Care Urgent Care – departments have reviewed antimicrobial choice to encourage more appropriate prescribing of co-amoxiclav. The Trust has purchased an information tool called Refine which can provide reports on drug use. Supply of medication from outpatients The outpatient departments have been – requested to review any letters that suggest patients should contact their GP for medicines supply to make it clear that medicines are not required and “immediately” should be requested in line with their GP’s normal procedures NEL Continence formulary final comments to be gathered for the next meeting. – Joanne Rowson to re-circulate. Action: JR Eye-Com update on minutes of previous meeting. – Terms of Reference Minor changes to the Terms of Reference were agreed. Paul – Fieldhouse will continue as chair. The updated terms of reference will be published on the APC website Action: JR Colostomy bags not discussed – Formulary annotation will be added for Cinacalcet/Specialist Endocrinology Services not discussed. – 5 APC Working Arrangements NICE TA & NG Updates (March/April). NICE guidance discussed: Noted IPG578 Noted NG68 Not recommended by NICE TA440
Review of the use of NOACs – Gemma McNally and Paulash Haider had discussed this. A range of novel oral anticoagulants are in use across the health economy. A strategy for the use of NOACs reflecting latest published evidence is required for discussion at a future APC. Action: PH Chapter 11 –It was agreed to request Mr Kotta to provide any final comments on Chapter 11. Action: AT Lurasidone – checking NAVIGO support the inclusion of lurasidone for prescribing in specialist care only. Action:AT NL CCG Prescribing formulary changes agreed at Engine Room - Net-formulary presentation of the formulary will be able to reflect preferred products proposed by CCGs. Co-Amoxiclav Prescribing in Primary and Secondary Care – Urgent Care departments have reviewed antimicrobial choice to encourage more appropriate prescribing of co-amoxiclav. The Trust has purchased an information tool called Refine which can provide reports on drug use. Supply of medication from outpatients – The outpatient departments have been requested to review any letters that suggest patients should contact their GP for medicines supply to make it clear that medicines are not required “immediately” and should be requested in line with their GP’s normal procedures NEL Continence formulary – final comments to be gathered for the next meeting. Joanne Rowson to re-circulate. Action: JR Eye-Com – update on minutes of previous meeting. Terms of Reference – Minor changes to the Terms of Reference were agreed. Paul Fieldhouse will continue as chair. The updated terms of reference will be published on the APC website Action: JR Colostomy bags – not discussed Formulary annotation will be added for Cinacalcet/Specialist Endocrinology Services – not discussed. 5 APC Working Arrangements NICE TA & NG Updates (March/April). NICE guidance discussed: IPG578 Noted NG68 Noted TA440 Not recommended by NICE
Item-4-APC-Minutes-11-May-2017.docx